These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 15377314

  • 1. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.
    Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A.
    Cephalalgia; 2004 Oct; 24(10):838-43. PubMed ID: 15377314
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 4. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine.
    Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM, BoNTA-009 Study Group.
    Pain Med; 2007 Sep; 8(6):478-85. PubMed ID: 17716321
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ, Lee S, Siu M, Ondovcik S, Lam K, Alabdullatif A, Zhang X, Machado M, Einarson TR.
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A in prophylactic treatment of migraine.
    Anand KS, Prasad A, Singh MM, Sharma S, Bala K.
    Am J Ther; 2006 Jul; 13(3):183-7. PubMed ID: 16772757
    [Abstract] [Full Text] [Related]

  • 8. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
    Freitag FG, Diamond S, Diamond M, Urban G.
    Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
    [Abstract] [Full Text] [Related]

  • 9. A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches.
    Relja M, Poole AC, Schoenen J, Pascual J, Lei X, Thompson C, European BoNTA Headache Study Group.
    Cephalalgia; 2007 Jun; 27(6):492-503. PubMed ID: 17428299
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin as preventive treatment for migraine: a randomized double-blind study.
    Petri S, Tölle T, Straube A, Pfaffenrath V, Stefenelli U, Ceballos-Baumann A, Dysport Migraine Study Group.
    Eur Neurol; 2009 Jun; 62(4):204-11. PubMed ID: 19622887
    [Abstract] [Full Text] [Related]

  • 11. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 13. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM, Schim JD, Chippendale TJ.
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [Abstract] [Full Text] [Related]

  • 14. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
    Schulte-Mattler WJ, Krack P, BoNTTH Study Group.
    Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC.
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [Abstract] [Full Text] [Related]

  • 16. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA, Protocol 125 study group.
    Headache; 2004 Jun; 44(6):581-6. PubMed ID: 15186302
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.
    Silberstein SD, Göbel H, Jensen R, Elkind AH, Degryse R, Walcott JM, Turkel C.
    Cephalalgia; 2006 Jul; 26(7):790-800. PubMed ID: 16776693
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W.
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [Abstract] [Full Text] [Related]

  • 19. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
    Sahai A, Khan MS, Dasgupta P.
    J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.